Content uploaded by David Shannahoff-Khalsa
Author content
All content in this area was uploaded by David Shannahoff-Khalsa
Content may be subject to copyright.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
!"342!#4
4HEOBJECTIVEOFTHISSTUDYWASTOCOMPAREEFFICACYOFTWO
MEDITATIONPROTOCOLSFORTREATINGPATIENTSWITHOBSESSIVECOM
PULSIVEDISORDER/#$0ATIENTSWERERANDOMIZEDTOTWO
GROUPSMATCHEDFORSEXAGEANDMEDICATIONSTATUSAND
BLINDEDTOTHECOMPARISONPROTOCOL4HEYWERETOLDTHETRIAL
WOULDLASTFORMONTHSUNLESSONEPROTOCOLPROVEDTOBE
MOREEFFICACIOUS)FSOGROUPSWOULDMERGEANDTHEGROUP
THATRECEIVEDTHELESSEFFICACIOUSTREATMENTWOULDALSOBE
AFFORDEDMONTHSOFTHEMOREEFFECTIVEONE4HESTUDYWAS
CONDUCTEDAT#HILDRENS(OSPITAL3AN$IEGO#ALIF0ATIENTS
WERESELECTEDACCORDINGTO$IAGNOSTICAND3TATISTICAL-ANUAL
OF-ENTAL$ISORDERS4HIRD%DITION2EVISED$3-)))2
CRITERIAANDRECRUITEDBYADVERTISEMENTSANDREFERRAL!TBASE
LINE'ROUPINCLUDEDADULTSANDADOLESCENTAND'ROUP
INCLUDEDADULTS'ROUPEMPLOYEDAKUNDALINIYOGA
MEDITATIONPROTOCOLAND'ROUPEMPLOYEDTHE2ELAXATION
2ESPONSEPLUS-INDFULNESS-EDITATIONTECHNIQUE"ASELINE
ANDMONTHINTERVALTESTINGWASCONDUCTEDUSINGTHE9ALE
"ROWN/BSESSIVE#OMPULSIVE3CALE9"/#33YMPTOMS
#HECKLIST2EVISED/BSESSIVE#OMPULSIVE3#,2/#
AND'LOBAL3EVERITY)NDEX3#,2'3)SCALES0ROFILE
OF-OODSSCALE0/-30ERCEIVED3TRESS3CALE033AND
0URPOSEIN,IFE0),TEST3EVENADULTSINEACHGROUPCOM
PLETEDMONTHSOFTHERAPY!TMONTHS'ROUPDEMON
STRATEDGREATERIMPROVEMENTS3TUDENTSINDEPENDENTGROUPS
TTESTONTHE9"/#33#,2/#AND'3)SCALESAND
0/-3ANDGREATERBUTNONSIGNIFICANTIMPROVEMENTSONTHE
033AND0),TEST!NINTENTTOTREATANALYSIS9"/#3FOR
THEBASELINEANDMONTHTESTSSHOWEDTHATONLY'ROUP
IMPROVED7ITHINGROUPSTATISTICS3TUDENTSPAIREDTTESTS
SHOWEDTHAT'ROUPSIGNIFICANTLYIMPROVEDONALLSIXSCALES
BUT'ROUPHADNOIMPROVEMENTS'ROUPSWEREMERGEDFOR
ANADDITIONALYEARUSING'ROUPTECHNIQUES!TMONTHS
THEFINALGROUP.IMPROVED
ANDRESPECTIVELYONTHE9"/#33#,2/#
3#,2'3)0/-3033AND0),0ANALYSISOF
VARIANCE4HISSTUDYDEMONSTRATESTHATKUNDALINIYOGATECH
NIQUESAREEFFECTIVEINTHETREATMENTOF/#$
#.33PECTRUMS
).42/$5#4)/.
/BSESSIVECOMPULSIVEDISORDER/#$ISONEOFTHE
MOSTDISABLINGOFTHEANXIETYDISORDERS
!CONDITION
WITHALIFELONGCOURSE/#$ISESTIMATEDTOBETHE
FOURTHMOSTCOMMONPSYCHIATRICDISORDERFOLLOWINGPHO
BIASSUBSTANCEABUSEDISORDERSANDTHEMAJORDEPRES
SIVEDISORDERSANDISTWICEASCOMMONASSCHIZOPHRENIA
ANDPANICDISORDER
/#$OFTENBEGINSDURINGCHILDHOOD
ORADOLESCENCEHASALIFETIMEPREVALENCERATEOF
TO
ANDHASPROVENTOBEREFRACTORYTOTRADITIONAL
INSIGHTORIENTEDPSYCHOTHERAPY
$AVID3HANNAHOFF+HALSAISRESEARCHGROUPDIRECTOROF4HE2ESEARCH'ROUPFOR-IND"ODY$YNAMICSATTHE)NSTITUTEFOR.ONLINEAR3CIENCE5NIVERSITYOF
#ALIFORNIA3AN$IEGOANDPRESIDENTOF4HE+HALSA&OUNDATIONFOR-EDICAL3CIENCE$EL-AR#!-S2AYISACONSULTINGPSYCHOTHERAPISTINPRIVATEPRACTICE
IN3AN$IEGO#!$R,EVINEISAPROFESSORINTHE$EPARTMENTOF0SYCHIATRYATTHE5NIVERSITYOF#ALIFORNIA3AN$IEGOANDCHAIRMANOFTHE$EPARTMENTOF
0SYCHIATRY#HILDRENS(OSPITALIN3AN$IEGO$R'ALLENWASANASSISTANTMEMBEROFTHE$EPARTMENTOF.EUROPHARMACOLOGYAT4HE3CRIPPS2ESEARCH)NSTITUTE
,A*OLLA#!ANDISNOWVICEPRESIDENTOFCLINICALRESEARCH#.3ANDCLINICALOPERATIONSAT0HARMACIA5P*OHN+ALAMAZOO-)$R3CHWARTZISASSISTANT
PROFESSORINTHE$EPARTMENTOF.EUROPHARMACOLOGYAT4HE3CRIPPS2ESEARCH)NSTITUTEANDAVISITINGSCHOLARAT4HE2ESEARCH'ROUPFOR-IND"ODY$YNAMICS
)NSTITUTEFOR.ONLINEAR3CIENCE$R3IDOROWICHISAVISITINGSCHOLARAT4HE2ESEARCH'ROUPFOR-IND"ODY$YNAMICS)NSTITUTEFOR.ONLINEAR3CIENCE
!CKNOWLEDGMENTS
#ONTRIBUTORS$AVID3HANNAHOFF+HALSAISTHEGUARANTORANDHADTHEORIGINALIDEAFORTHESTUDYOBTAINEDGRANTFUNDINGWITH$R,EVINEANDACTEDAS
THEPRINCIPALINVESTIGATOR4HEEXPERIMENTWASDESIGNEDBY$AVID3HANNAHOFF+HALSA$R,EVINE-S2AY$R'ALLEN$R3CHWARTZAND$R3IDOROWICH
$AVID3HANNAHOFF+HALSADESIGNEDTHEGROUPPROTOCOLAND$AVID3HANNAHOFF+HALSAAND-S2AYDESIGNEDTHEGROUPPROTOCOL$ATAANALYSESWERE
CARRIEDOUTBY$AVID3HANNAHOFF+HALSAAND-S2AYWITHADVICEFROM$RS'ALLEN,EVINE3CHWARTZAND3IDOROWICH!LLAUTHORSCONTRIBUTEDTOTHE
DISCUSSIONOFCOREIDEAS$AVID3HANNAHOFF+HALSAHADRESPONSIBILITYFORWRITINGTHEPAPERWITHCONTRIBUTIONSFROMALLOTHERAUTHORS
4HEAUTHORSTHANK0AUL3HRAGG"3-3AND2EENA$EUTSCH0H$5NIVERSITYOF#ALIFORNIA3AN$IEGO'ENERAL#LINICAL2ESEARCH#ENTERFORBIOSTATISTICALASSISTANCE
&UNDING"IOSTASTICALASSISTANCEWASSUPPORTEDINPARTBYRESEARCHGRANT-22FROMTHE'ENERAL#LINICAL2ESEARCH#ENTER0ROGRAM.ATIONAL
)NSTITUTESOF(EALTH"ETHESDA-$)NADDITIONTHISWORKWASSUPPORTEDINPARTBYRESEARCHGRANT222FROMTHE/FFICEOF!LTERNATIVE-EDICINE
.ATIONAL)NSTITUTESOF(EALTH"ETHESDA-$TO$AVID3HANNAHOFF+HALSAANDBYTHE7ALETZKY#HARITABLE,EAD4RUSTAND-R*OHN$E"EER
#ORRESPONDENCE$AVID33HANNAHOFF+HALSA4HE2ESEARCH'ROUPFOR-IND"ODY$YNAMICS)NSTITUTEFOR.ONLINEAR3CIENCE5NIVERSITYOF#ALIFORNIA3AN$IEGO
'ILMAN$R,A*OLLA#!nDSK ROUTHUCSDEDU
#ONFLICTOFINTERESTNONE
&EATURE!RTICLE/RIGINAL2ESEARCH
2ANDOMIZED#ONTROLLED4RIALOF9OGIC
-EDITATION4ECHNIQUESFOR0ATIENTS7ITH
/BSESSIVE#OMPULSIVE$ISORDER
"Y$AVID33HANNAHOFF+HALSA,ESLIE%2AY-3-&##3AUL,EVINE-$
#HRISTOPHER#'ALLEN-$0H$"ARRY*3CHWARTZ0H$AND*OHN*3IDOROWICH0H$
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
0HARMACOLOGICMANAGEMENTANDBEHAV
IORTHERAPY"4CONSISTINGOFEXPOSUREAND
RESPONSEPREVENTIONAREUSEDINTREATMENT
(OWEVERITHASBEENREPORTEDTHATTO
OFPATIENTSSHOWONLYMINIMALIMPROVE
MENTORNOCHANGEWITHTHEUSEOFSEROTONIN
REUPTAKEINHIBITORSALONE
ANDTHATUPTOONE
THIRDOFPATIENTSREMAINUNIMPROVEDAFTER
APPARENTLYADEQUATEDRUGTREATMENT
4HESE
PATIENTSHAVEBEENCALLEDDRUGTREATMENT
RESISTANT
)NRESPONDERSMEDICATIONPRO
DUCESASYMPTOMREDUCTIONOFTOAT
BESTANDPATIENTSTENDTOREMAINCHRONICALLY
SYMPTOMATICTOSOMEDEGREEDESPITEUSEOF
THEMOSTEFFECTIVEPHARMACOLOGICINTERVEN
TIONS
!LTHOUGHADECREASEOFTOIN
THEMEAN9ALE"ROWN/BSESSIVE#OMPULSIVE
3CALE9"/#3
SCORESMAYREPRESENTACLINI
CALLYMEANINGFULCHANGEINSYMPTOMSEVERITY
THEREISCLEARLYROOMFORIMPROVEMENT
$ISCONTINUATIONOFPHARMACOLOGICTREAT
MENTISALMOSTALWAYSASSOCIATEDWITHCOM
PLETE RELAPSE
)N ADDITION+OBAKET
AL
RECENTLYCONDUCTEDAMETAANALYSISTO
COMPARE"4WITHPHARMACOLOGICTHERAPY
THATCONSISTEDOFSEROTONINREUPTAKEINHIBI
TORSCONCLUDINGTHATTHETWOTREATMENTSWERE
COMPARABLE4HESIZEABLEPERCENTAGEOFTREAT
MENTREFRACTORYPATIENTSTHELIMITEDSHORT
ANDLONGTERMSUCCESSANDADVERSEEFFECTSOF
MEDICATIONANDTHEFACTTHATIMPROVEMENTIN
RITUALIZINGWITH"4OFTENFAILSTOBRINGABOUTA
SIGNIFICANTREDUCTIONINGENERALIZEDANXIETY
ORDEPRESSION
ALLSUGGESTANEEDTOINVESTI
GATEALTERNATIVETREATMENTMODALITIES
2ECENTLYASMALLUNCONTROLLEDTRIALDEM
ONSTRATEDTHATKUNDALINIYOGA+9TECHNIQUES
ARESUCCESSFULINIMPROVING/#$SYMP
TOMS
&IVEOFEIGHTPATIENTSCOMPLETEDTHIS
MONTHINVESTIGATIONSHOWINGAMEAN
9"/#3IMPROVEMENTOF4HECOM
PLETERS ALSO ACHIEVED IMPROVEMENTS OF
ANDRESPECTIVELYONTHE
3YMPTOM#HECKLIST2EVISED/BSESSIVE
#OMPULSIVE3#,2/#
AND'LOBAL
3EVERITY)NDEX'3)SUBSCALES)NTHESEFIVE
PARTICIPANTS/#$WASPREVIOUSLYSTABILIZED
WITHFLUOXETINEFORMORETHANMONTHSPRIOR
TOTHESTARTOFTHESTUDY/FTHEFIVETHREE
WERECOMPLETELYFREEOFMEDICATIONFORATLEAST
MONTHSPRIORTOSTUDYENDANDTHENEEDFOR
MEDICATIONINTHEREMAININGTWOWASSIGNIF
ICANTLYREDUCED/NEYEARLATERFOUROFTHE
FIVEPATIENTSHADREMAINEDOFFMEDICATIONFOR
PERIODSRANGINGBETWEENANDMONTHS
WITHLASTINGIMPROVEMENT
4HEABOVEFINDINGSOFSUSTAINEDANDCLINI
CALLYSIGNIFICANTIMPROVEMENTWEREOBTAINED
INANUNCONTROLLEDTRIAL(EREWEREPORT
RESULTSAFTERCOMPARINGTHEPROTOCOLFROMTHE
UNCONTROLLEDTRIAL
WHICHINCLUDEDAYOGIC
BREATHINGTECHNIQUECLAIMEDTOBESPE
CIFICFORTREATING/#$WITHAVERYDIFFERENT
MEDITATIONPROTOCOL4HEHYPOTHESISTESTED
HEREISTHATTHISDISORDERSPECIFICTECHNIQUE
WOULDBEREQUIREDFOREFFICACYANDTHATMED
ITATIONTECHNIQUESINGENERALMAYNOTBE
EFFECTIVE0RELIMINARYRESULTSATMONTH
OFTHISMONTHTRIALFROMONEOFTHESIX
SCALESREPORTEDHERE9"/#3WEREPUB
LISHEDEARLIER
-%4(/$3
0ROTOCOL
0ATIENTSWITH/#$WERERECRUITEDTHROUGH
ATELEVISIONNEWSCOMMENTARYNEWSPAPER
ADVERTISEMENTANDPHYSICIANREFERRAL!LL
BUTONEPATIENTHADAPREVIOUSPRINCIPAL
DIAGNOSISOF/#$
)NCLUSION#RITERIA
!LLDIAGNOSESWERECONFIRMEDINASEMI
STRUCTUREDINTERVIEWFORSUITABILITYUSING
$IAGNOSTICAND3TATISTICAL-ANUALOF-ENTAL
$ISORDERS4HIRD%DITION2EVISED
$3-
)))2CRITERIA FOR/#$WHICH
REQUIRESSYMPTOMSTOBEPRESENTFORAMINI
MUMOFMONTHSBEFOREDECLARINGADIAGNO
SISOF/#$!MINIMUMSCOREOFONTHE
9"/#3FORTHEITEMTOTALWASREQUIRED
FORADULTS)FTHEPATIENTSWERETAKINGMEDICA
TIONTHEYHADTOBEDOSESTABILIZEDFORATLEAST
MONTHSPRIORTOENTRY4HEMINIMUMAGEFOR
INCLUSIONWASYEARS
%XCLUSION#RITERIA
0ATIENTSWEREEXCLUDEDIFTHEYSMOKEDHAD
ASUBSTANCEABUSEDISORDERORHADSPINALOR
OTHERPHYSICALLYLIMITINGPROBLEMSTHATCOULD
INTERFEREWITHTHEMEDITATIONPRACTICE4HESE
PROBLEMSINCLUDEDBEINGEXCESSIVELYOVER
WEIGHTSEIZUREDISORDERSPULMONARYDISORDERS
EGSEVEREASTHMAOREMPHYSEMAHYPER
TENSIONSINCETHE+9PROTOCOLINCLUDESTWO
TECHNIQUESFORHOLDINGTHEBREATHANDTENSING
MUSCLESANDOTHERCARDIOVASCULARPROBLEMS
!LSOEXCLUDEDWEREPATIENTSWITHTHEFOL
LOWING$3-)))2PSYCHIATRICCONDITIONSAS
THEIRPRIMARYDISORDERSCHIZOPHRENIAMAJOR
DEPRESSIVEDISORDERBIPOLARDISORDERMENTAL
RETARDATIONANOREXIANERVOSAANDBULIMIA
NERVOSA0ATIENTSWITH4OURETTESYNDROME
&EATURE!RTICLE/RIGINAL2ESEARCH
h4HEHYPOTHESIS
TESTEDHEREISTHAT
THISDISORDERSPECIFIC
TECHNIQUEWOULD
BEREQUIREDFOREFFICACY
ANDTHATMEDITATION
TECHNIQUESINGENERAL
MAYNOTBEEFFECTIVEv
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
TRICHOTILLOMANIAORNAILBITINGASTHEIRONLY
COMPULSIONWEREALSOEXCLUDEDASWERE
PATIENTSWITHOUTREGULARTRANSPORTATIONTOTHE
STUDYSITE
)NFORMED#ONSENT
0RIORTOENROLLMENTALLPATIENTSWERE
INFORMEDTHATTHISWOULDBEACONTROLLEDSTUDY
COMPARINGTWOMEDITATIONPROTOCOLSWITHTEST
INGATMONTHINTERVALSTODETERMINEIFONE
PROTOCOLWASSUPERIOR)FONEPROTOCOLPROVED
TOBESUPERIORTHEGROUPSWOULDBECOMBINED
4HOSEWHOHADUSEDTHELESSEFFICACIOUSPRO
TOCOLINITIALLYWOULDALSORECEIVEMONTHS
OFTHEMOREEFFICACIOUSPROTOCOLALLOWING
FORTWOPOSSIBLESTUDYPHASES0ATIENTSWERE
INFORMEDTHATTHEYCOULDNOTBEGINNEWMEDI
CATIONSFORANYPSYCHIATRICDISORDERSDURING
THESTUDYIFTHEYWISHEDTOREMAINENROLLED
4HEYWEREALSOTOLDTHATTHEYWERENOTALLOWED
TOPARTICIPATEINOTHERFORMSOFTHERAPYFOR
/#$WHILEPARTICIPATINGINTHESTUDY4HEY
WOULDHOWEVERBEALLOWEDTOREDUCEORELIMI
NATETHEIRESTABLISHEDMEDICATIONS
!FTERDESCRIBINGTHESTUDYANDTHEPOSSIBLE
ADVERSEEFFECTSIETEMPORARYMUSCLESORENESS
WEOBTAINEDWRITTENINFORMEDCONSENTFROMALL
PARTICIPANTS4HESTUDYWASCONDUCTEDINCOM
PLIANCEWITHTHE#ODEOF%THICSOFTHE7ORLD
-EDICAL!SSOCIATION$ECLARATIONOF(ELSINKI
)NTERVENTIONS
7EEKLYMEETINGSWEREHELDON7EDNESDAY
EVENINGSFROMTO0-'ROUPWAS
INSTRUCTEDBY$33+ANEXPERTWITHYEARS
OFPERSONALANDTEACHINGEXPERIENCEIN+9
THERAPYBUTNOFORMALTRAININGASAPSYCHO
THERAPIST'ROUPEMPLOYEDTHE+9PROTOCOL
WHICHREQUIREDAPPROXIMATELYHOURTOCOM
PLETE!LLPATIENTSWEREINSTRUCTEDTOPRACTICE
THEIRRESPECTIVEPROTOCOLSONADAILYBASISTOTHE
BESTOFTHEIRABILITIESONALLSUBSEQUENTDAYS
!COMPLETEDESCRIPTIONOFTHE+9PROTO
COLWASPUBLISHEDPREVIOUSLYBY3HANNAHOFF
+HALSA
)TINCLUDESEIGHTPRIMARYTECHNIQUES
INCLUDING AYOGIC BREATHINGTECHNIQUE
FORTREATING/#$ANDTHREENONMANDATORY
TECHNIQUES
4HESPECIFICYOGICTECHNIQUE
FORTREATING/#$
REQUIRESBLOCKINGTHE
RIGHTNOSTRILATHUMBTIPORSECUREPLUGCAN
BEUSEDWITHSLOWDEEPINSPIRATIONTHROUGH
THELEFTNOSTRILBREATHRETENTIONANDSLOW
COMPLETEEXPIRATIONTHROUGHTHELEFTNOSTRIL
FOLLOWEDBYALONGBREATHHOLDINGOUTPERIOD
4HISPATTERNISCONTINUEDFORAMAXIMUMOF
MINUTES4HEPATIENTISINSTRUCTEDTOMAKE
EVERYEFFORTTOMAXIMIZETHEFOURPHASESOFTHE
BREATHCYCLEUNTILTHECOMPLETEBREATHCYCLE
EQUALSMINUTEWITHTHEFOURRESPECTIVE
PHASESEACHLASTINGSECONDSTHUSPERFECT
INGTHETECHNIQUE
4HISPURPORTEDLY/#$SPECIFICTECHNIQUEIS
ONEOFMANYMEDITATIONTECHNIQUESINTHE+9
SYSTEMTAUGHTBY9OGI"HAJANTHATARECLAIMED
TOBEUSEFULFORTREATINGSPECIFICPSYCHIATRIC
DISORDERS
3OMEOFTHEOTHERTECHNIQUESIN
THISPROTOCOLAREALSOCLAIMEDTOBEUSEFULFOR
TREATINGANXIETYDISORDERSASWELLASANGERAND
FEAR
4HEACTUALDATESOFDISCOVERYOFTHESE
TECHNIQUESAREUNKNOWN$33+LEARNED
THE/#$SPECIFIC+9TECHNIQUEINDUR
INGHISEARLYYEARSOFTRAININGWITHTHISYOGIC
SYSTEM(EFIRSTTESTEDITWITHTHEREMAINDEROF
THEPROTOCOLINANUNCONTROLLEDTRIAL
'ROUP WAS INSTRUCTED BY,%2A
LICENSEDTHERAPISTWITHYEARSOFPERSONAL
ANDCLINICALEXPERIENCEWITHTHEPOPULAR
2ELAXATION2ESPONSE22
AND-INDFULNESS
-EDITATION--TECHNIQUES
'ROUP
USEDEACHOFTHESETECHNIQUESFORMINUTES
"RIEFLYDESCRIBED22AND--ARERELATIVELY
PASSIVETECHNIQUES22REQUIRESACONSTANT
MENTALFOCUSANDREPETITIONOFASELFSELECTED
SPECIALWORDORPHRASE--REQUIRESTHE
CONSCIOUSOBSERVATIONOFTHOUGHTSWHILETHE
INDIVIDUALPASSIVELYOBSERVESTHEINSPIRATION
ANDEXPIRATIONOFTHEBREATHCYCLE
!SSESSMENTS
6ARIOUSPSYCHOLOGICALTESTSWEREADMINIS
TEREDASSELFRATINGMEASURES4HE9"/#3
MEASURESBOTHOBSESSIONSANDCOMPULSIONS
ANDALSOYIELDSACOMBINEDORTOTALSCORE4HE
9"/#3WHICHISUSUALLYADMINISTEREDIN
ASEMISTRUCTUREDINTERVIEWWASGIVENHERE
INAGROUPFORMATWITHEXPLANATIONAFTERTHE
9"/#3SYMPTOMSCHECKLIST)NARECENT
REVIEW OF STUDIES
EMPLOYMENT OF THE
9"/#3ASACOMPUTERADMINISTEREDCLINI
CALRATINGSCALEANDATALKINGCOMPUTERTELE
PHONEADMINISTEREDVERSIONWERECOMPARED
WITHTHESTANDARDCLINICIANADMINISTERED
VERSION2ESULTSSHOWEDNOSIGNIFICANTDIFFER
ENCEINTHEMODESOFADMINISTRATION
4HE3#,2INCLUDESASCALEFOROBSES
SIONSANDCOMPULSIONS/#ASWELLASTHE
'3)COMPOSITETHATREFLECTSNINESCALES
OBSESSIONSCOMPULSIONSANXIETYDEPRESSION
PARANOIDIDEATIONSOMATIZATIONINTERPER
SONALSENSITIVITYHOSTILITYPHOBICANXIETYAND
PSYCHOTICISM4HE0ROFILEOF-OOD3CALE
0/-3
MEASURESSIXVARIABLESTENSION
&EATURE!RTICLE/RIGINAL2ESEARCH
h4HE+9PROTOCOL
SHOWEDSIGNIFICANTLY
GREATERIMPROVEMENT
ONTHE9"/#3BOTH
3#,2SCALESAND
THE0/-3ANDGREATER
BUTNONSIGNIFICANT
IMPROVEMENTONTHE
033AND0),SCALESv
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
DEPRESSIONANXIETYVIGORFATIGUEANDCONFU
SIONTHATAREREPRESENTEDBYTHE4OTAL-OOD
$ISORDER4-$INDEX4HE0ERCEIVED3TRESS
3CALE033
MEASURESTHELEVELOFSTRESSTHAT
THEPATIENTPERCEIVES&INALLYTHE0URPOSEIN
,IFE0),
TESTMEASURESHOWMUCHPURPOSE
ANDMEANINGTHEPATIENTPERCEIVESINHISOR
HERLIFE"OTHTHE9"/#3AND3#,2/#
HAVEBEENSHOWNTOBEINTERNALLYCONSISTENT
ANDSENSITIVETOCHANGESWITHBEHAVIORAL
MEASURES
!LLTESTSWEREADMINISTEREDTOALLPATIENTS
ASONEGROUPATBASELINEPRIORTOTHEIRKNOW
INGTHEIRGROUPASSIGNMENTSWEEKSPRIOR
TOTHERAPY4HEFIRSTMONTHTESTSWEREALSO
ADMINISTEREDTOTHETWOGROUPSTOGETHER
&EATURE!RTICLE/RIGINAL2ESEARCH
&)'52%2%#25)4-%.42!.$/-):!4)/.!.$!,,/#!4)/./&0!4)%.43
ADULTSREPONDEDTOCALLFORPATIENTSANDSCREENED
ADOLESCENTSSCREENED
ADULTSFAILEDTOMEETINITIALCRITERIA
ADOLESCENTFAILEDTOMEETCRITERIA
!TMONTHS.ADULTS
ADULTSLOSTADOLESCENTLOST
!TMONTHS.ADULTS
ADULTSLOST
!TMONTHS.ADULTS
ADULTLOST
!TMONTHSFINALEND.ADULTS
ADULTSADOLESCENTADDAMONTHMERGING
!TMONTHMERGINGOFGROUPSTO+UNDALINIYOGA.
ADULTSFROM'ROUPADULTSFROM'ROUPNEW
ADULTSNEWADOLESCENTBOXTORIGHT
"EFOREMONTHTESTINGADULTSADOLESCENTLOST
2ELAXATION2ESPONSE-INDFULNESS-EDITATION
'ROUP.ADULTS
ADULTSCOMPLETEDTREATMENT.
ADULTSLOSTTOSTUDYBEFOREMONTHTESTING.
+UNDALINI9
OGA'ROUP.ADULTS
ADOLESCENT
ADULTSCOMPLETEDTREATMENT.
ADULTSLOSTTOSTUDYBEFOREMONTHTESTING.ADOLESCENTLOST
2ANDOMIZATIONOF!DULTS
ADULTSFULFILLEDINITIALCRITERIA
ADOLESCENTSFULFILLEDINITIALCRITERIAAGETOADMITLATERWHENAGEMEETINGMINIMUMAGETO
PARTICIPATEIFSTUDYHASOPENINGS
ADULTSALLOCATEDTOTREATMENTAFTERCOMPLETINGPRETREATMENTASSESSMENT
ADOLESCENTSALLOCATEDTOTEATMENTAFTERCOMPLETINGPRETREATMENTASSESSMENT
ADULTSFAILEDTOENTERATPRETREATMENTASSESSMENT
ADULTSACTUALLYPARTICIPATEDENTEREDRANDOMIZATIONTOTREATMENT
ADULTSFAILEDTOENTERTREATMENT
ADOLESCENTACTUALLYPARTICIPATEDENTEREDTREATMENT
ADOLESCENTFAILEDTOENTERTREATMENT
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
-ASKINGAND2ANDOMIZATION
/NTHESAMEEVENINGIMMEDIATELYAFTER
BASELINETESTINGPATIENTSWEREMATCHEDFOR
AGESEXANDMEDICATIONSTATUS!FTERFORMING
MATCHEDGROUPSGROUPTOTHERAPYPAIRINGS
WEREDETERMINEDBYACOINTOSS0ARTICIPANTS
HADNOKNOWLEDGEOFTHEMEDITATIONPROTOCOL
CONTENTSPRIORTOGROUPASSIGNMENTSOROFTHE
CONTENTOFTHEOTHERPROTOCOLAFTERRANDOM
IZATION$33+KNEWTHECONTENTSOFBOTH
PROTOCOLS,%2WASNOTINFORMEDABOUTTHE
PROTOCOLCONTENTFORGROUP
4REATMENT'ROUPS
4HEFLOWCHART&IGUREDESCRIBESTHE
RECRUITMENTRANDOMIZATIONANDALLOCATIONOF
PATIENTS4ABLEDESCRIBESDEMOGRAPHICSOF
THEPATIENTSINGROUPSANDINPHASETHE
FIRSTMONTHPERIODANDPHASEFOLLOWING
MERGEROFTHEGROUPSATMONTHS4WENTYONE
ADULTSWOMENSEVENMENANDONEADOLES
CENTGIRLPATIENTAGEDYEARSENROLLEDIN
PHASE)NPHASETWOADULTWOMENPATIENTS
ANDANDONEADOLESCENTBOYPATIENT
AGEDYEARSENTEREDTHEPROTOCOLALONGWITH
ONEWOMANPATIENTWHOHADDROPPEDOUT
AFTERWEEKSWITHGROUP
/FTHEPATIENTSHADRECEIVEDONEOR
MOREPRIORFORMSOFTHERAPYMEDICATION"4
ANDORPSYCHOTHERAPYFOR/#$ANDALLBUT
THREEBEGANEXPERIENCINGSYMPTOMSDURING
EARLYCHILDHOODORADOLESCENCE4HEPATIENT
POPULATIONHADACHARACTERISTICARRAYOF/#
SYMPTOMSANDSEVERITIESALLPRESENTED
WITHMULTIPLEOBSESSIONSANDCOMPULSIONS
3EE3HANNAHOFF+HALSA
FORACOMPLETE
DESCRIPTIONOFTHESE9"/#3OBSESSIONSAND
COMPULSIONS&OURPATIENTSAND
ALSOHADTRICHOTILLOMANIA
!TTHEBEGINNINGOFPHASEGROUPCON
SISTEDOFPARTICIPANTSINCLUDINGEIGHT
WOMENANDTHEADOLESCENTGIRL4ABLE
PATIENTSnAND3UBSEQUENTLYPRIOR
TOTHREEMONTHSONEPATIENTPATIENTAGED
&EATURE!RTICLE/RIGINAL2ESEARCH
4!",%0!4)%.4$%-/'2!0()#3
(ISTORYo
!GEAT 2ELATIVES
0ATIENT !GE /NSET -ARITAL 0SYCHIATRIC 0HYSICAL 7ITH
.O 3EX 9EARS9EARS "4 -EDS 0SYCH%MPLOYED 3TATUS (ISTORY $ISEASE /#$
& M $EP "0
& 04 $
& 34 3 "0
- &4 3
& #H 34 3 $EP!NR"UL
& S M
- 34 3
& &4 M
& &4 M "0
- 3 30$EP!$$ #&3
& 04 $
& &4 M $EP "0
- 04 $ "$
& 4EENS M 3$
- &4 3
- &4 M
& &4 M $EP
- &4 M $EP
& #H 34 3 $EP
& #H $
& 3 !NR"UL
& #H 34 3 $EP
& 04 M
& #H 34 3 $EP!$($
- 34 3 !$($$EP43
"4BEHAVIORAL THERAPY -EDSPREVIOUS TREATMENT WITH MEDICATION 0SYCHPREVIOUS PSYCHOTHERAPY &FEMALE -MALE CHCHILDHOOD ONSET &4FULL
TIME 04PARTTIME 34STUDENT MMARRIED $DIVORCED 3SINGLE $EPDEPRESSION !NRANOREXIA "ULBULIMIA 30SOCIAL PHOBIA !$$ATTENTION
DEFICIT DISORDER "$BIPOLAR DISORDER 3$SLEEP DISORDER !$($ATTENTION DEFICITHYPERACTIVITY DISORDER 434OURETTES SYNDROME "0BACK PAIN
#&3CHRONICFATIGUESYNDROME
4HEMEANAGEOFTHEPARTICIPANTSWASYEARS3$THEMEANAGEOF/#$ONSETWHENKNOWNWASYEARS3$
o
/VERALL OF PARTICIPANTSHAD PREVIOUSLY BEEN TREATEDWITH "4 HADRECEIVED MEDICATION AND HAD TRIED SOMEFORM OFINDIVIDUALLY BASED
PSYCHOTHERAPY )N ADDITION WERE EITHER EMPLOYED OR STUDENTS WERE MARRIED WERE SINGLE AND WERE CURRENTLY DIVORCED
&IFTYTWOPERCENTHADAHISTORYOFAPSYCHIATRICDISORDEROTHERTHAN/#$HADACURRENTPHYSICALDISORDERANDHADARELATIVEWITH/#$
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
YEARSWASELIMINATEDFROMTHESTUDYDUE
TOHERAPPARENTNEEDTOINCREASEHERDOSEOF
ABENZODIAZEPINE'ROUPPATIENTSn
INCLUDEDADULTSSIXWOMEN4HEMEAN
AGEWASYEARSSTANDARDDEVIATION
;3$=NRANGEnFORTHEGROUP
ADULTSANDYEARS3$N
RANGEnFORTHEGROUPADULTS%ACH
GROUPINITIALLYHADSIXADULTSTREATEDPHARMA
COLOGICALLYFOR/#$
3TATISTICAL!NALYSIS
7ECHOSETHE9"/#3ASTHEPRIMARYOUT
COMEMEASUREFORHYPOTHESISTESTINGATTHE
LEVELOFSIGNIFICANCETWOTAILED3TUDENTS
TTEST7EBASEDOURPOWERANALYSISFORGROUP
SIZESONOURPREVIOUSPILOTSTUDY
ANDFOUND
THATASAMPLESIZEOFEIGHTSUBJECTSWOULD
ALLOWUSTOTESTOURHYPOTHESISWITHα
ANDAPOWERORGREATER3TATISTICALANALY
SESWEREPERFORMEDUSINGTWOTAILED3TUDENTS
TTESTSWITH0#).&/TIMEORIENTED
DATAMANAGEMENTANALYSISSYSTEMSOFTWARE
2ETRIEVER$ATA3YSTEMS3EATTLE7ASHAND
"IOMEDICAL$ATA0ACKAGE3TATISTICAL3OFTWARE
5NIVERSITYOF#ALIFORNIA0RESS
2%35,43
0ARTICIPANT&LOW
4HESTUDYHADTWOPHASES0HASEWASA
MONTHRANDOMIZEDCONTROLLEDTRIALWITH
ONLYONEOFTHETWOTHERAPIESLEADINGTO
IMPROVEMENTS)N0HASETHEGROUPSWERE
MERGEDANDTHEMOREEFFICACIOUSPROTOCOL
FROMPHASEWASEMPLOYEDFORANADDITIONAL
MONTHS&IGUREDESCRIBESTHERECRUITMENT
RANDOMIZATIONANDALLOCATIONOFPATIENTS
!NALYSISOF0HASE)
4HESEPARATEGROUPBASELINEMEANS3$
ANDCONFIDENCEINTERVAL#)BASELINE
VALUESFORALLSCALESARELISTEDIN4ABLE
9"/#3SCORESSHOWEDTHATTHEGROUPSWERE
MATCHEDFORTHESEVERITYOF/#SYMPTOMS
$URINGTHEFIRSTMONTHPERIODEACHGROUP
HADTHREEADULTSWITHDRAWNOTINCLUDINGTHE
WOMANELIMINATEDFROMGROUPFORINCREASING
HERDOSEOFABENZODIAZEPINE4HREEPATIENTS
DROPPEDOUTOFGROUPAYEAROLDWOMAN
WITHA9"/#3SCOREOFAYEAROLD
WOMANWITHA9"/#3OFANDAYEAR
OLDMANWITHA9"/#3OF4HREEPATIENTS
ALSODROPPEDOUTOFGROUPAYEAROLD
WOMANWITHA9"/#3OFAYEAROLD
WOMANWITHA9"/#3OFANDAYEAR
OLDMANWITHA9"/#3OF4HEGROUP
ADOLESCENTYEAROLDGIRLWITHA9"/#3
OFALSOWITHDREW
$ROPOUTSCHOSENOTTORETAKETESTSLEAVING
EACHGROUPWITHSEVENADULTS4HERECALCULATED
MEANBASELINE9"/#3SCORESWEREFOR
THESEVENADULTSINGROUP3$#)
nANDFORTHESEVENADULTS
INGROUP3$#)n
4HETWONEWMEANSWERETESTEDFORSTATISTICAL
DIFFERENCESUSINGATWOTAILEDINDEPENDENT
GROUPS3TUDENTSTTESTTHEDIFFERENCESWERE
NOTSIGNIFICANTT0
'ROUPDIFFERENCESPREVSPOSTDIFFER
ENCESANDTHEGROUPINTERACTIONFORTHEFIRST
MONTHSOFTHERAPYWEREEVALUATEDUSINGTHE
9"/#34HEMONTHMEANTOTAL9"/#3
SCORESWEREFORGROUP3$.
#)nANDFORGROUP
3$.#)n5SING
&EATURE!RTICLE/RIGINAL2ESEARCH
4!",%!$5,4-/.4("!3%,).%-%!352%3
'ROUPN 'ROUPN
-EAN3$ #) -EAN3$ #)
9"/#3
4OTALSOBSESSIONSCOMPULSIONS n n
/BSESSIONS n n
#OMPULSIONS n n
3#,2
/#SCALE n n
'3)SCALE n n
0/-34-$SCORE n n
033 n n
0), n n
9"/#39ALE"ROWN /BSESSIVE #OMPULSIVE 3CALE 3#,23YMPTOM #HECKLIST 2EVISED /#OBSESSIVE COMPULSIVE '3)GLOBAL SEVERITY INDEX
0/-30ROFILEOF-OODS3CALE-$4OTAL-OOD$ISORDERINDEX0330ERCEIVED3TRESS3CALE0),0URPOSEIN,IFETEST
-EAN VALUES STANDARD DEVIATIONS 3$SAND CONFIDENCE INTERVALS #)S FOR THE 9"/#3 TOTALS;OBSESSIONSITEMS n= ;COMPULSIONSITEMSn=
3#,2RAWSCORESFOR/#AND'3)SCALES0/-3TOTALMOODDISORDERRAWSCORES033AND0),FORTHEMONTHBASELINESFORGROUPSANDWITHTHE
ORIGINALADULTPATIENTSINEACHGROUPBEFOREOTHERSWITHDREW.INGROUPFORTHE9"/#3ONLYINCLUDESTHEADULTWOMANELIMINATEDDUETODRUG
COMPLICATIONSANDTHEADOLESCENTGIRL!LLTESTSWERETAKENPRIORTOTHEPATIENTSKNOWLEDGEOFGROUPASSIGNMENTS
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
ATWOWAYMIXEDMODELANALYSISOFVARIANCE
WEFOUNDTHATTHEINTERACTIONTERMREFLECTING
THEPOTENTIALDIFFERENTIALEFFECTSOFEACHTHER
APYWASSIGNIFICANT&;=0
INDICATINGTHATTHECHANGEINGROUPWAS
GREATERTHANTHATINGROUP4HEMEANGROUP
CHANGESIN9"/#3TOTALSFROMBASELINETO
MONTHSWEREFORGROUP3$
#)nANDFORGROUP
3$#)TO!TWO
TAILEDPAIRED3TUDENTSTTESTSHOWEDASIG
NIFICANTIMPROVEMENTOFT
0FORGROUPANDONLYAPOSITIVE
BUTNONSIGNIFICANTIMPROVEMENTOFFOR
GROUPT0
!NINTENTTOTREATANALYSISFORTHE9"/#3
USINGAPAIRED3TUDENTSTTESTTWOTAILEDWAS
PERFORMEDFORGROUP.ADULTSAND
ADOLESCENTANDGROUP.ADULTS4HE
MONTHBASELINESCORESFORTHOSELEAVINGTHE
STUDYWERECARRIEDFORWARDTOMONTHS4HE
GROUPMONTHMEANWAS3$
#)nANDTHEMONTH
MEANWAS3$#)n
4HEGROUPMONTHMEANWAS
3$#)nANDTHE
MONTHMEANWAS3$
#)n'ROUPSHOWEDASIGNIFI
CANT9"/#3IMPROVEMENTOFT
0ANDGROUPSHOWEDAPOSITIVEBUT
NONSIGNIFICANTTRENDTOWARDIMPROVEMENTOF
T0
4ABLESHOWSTHEMONTHANDMONTH
MEANSCORES3$AND#)SFORALLSCALES
ASWELLASTHERESULTSOFASTATISTICALhCOM
PLETERvANALYSISFORGROUPDIFFERENCESUSING
3TUDENTSINDEPENDENTGROUPSTTESTTWO
TAILED)TMUSTBENOTEDTHAT4ABLEDOESNOT
INCLUDETHERESULTSFORTHETHREEDROPOUTSFOR
EACHGROUPEXPLAININGTHEDIFFERENCESINN
VALUESCOMPAREDWITH4ABLE,OWERSCORES
ONALLSCALESEXCEPTTHE0),TESTREFLECTAN
IMPROVEDSTATE4HE+9PROTOCOLSHOWED
SIGNIFICANTLYGREATERIMPROVEMENTONTHE
9"/#3BOTH3#,2SCALESANDTHE
0/-3 AND GREATER BUT NONSIGNIFICANT
IMPROVEMENTONTHE033AND0),SCALES
!PAIRED3TUDENTSTTESTTWOTAILEDWAS
USEDTOCOMPAREWITHINGROUPDIFFERENCESAT
AND MONTHS FOR ALL SIX SCALES 4HE
9"/#33#,2/#AND'3)SCALES
0/-3033AND0),TESTALLSHOWEDSIGNIFI
CANCEFORTHEGROUPPROTOCOLN0
ANDRESPEC
TIVELY4HERESPECTIVEIMPROVEMENTSWERE
AND.OSCALEWASSIGNIFICANTFOR
GROUPNWITHRESPECTIVECHANGESOF
&EATURE!RTICLE/RIGINAL2ESEARCH
4!",%!$5,4-/.4(-%!."!3%,).%!.$-/.4(-%!352%3
)NDEPENDENT'ROUPS3TUDENTST4EST4WO4AILEDFOR#OMPARING%FFICACYOF'ROUPVS'ROUP
-ONTH3$#) -ONTH3$#) -EAN$IFFERENCE3$#) 06ALUE
9"/#34OTALS
'ROUPN n n n
'ROUPN n n n
3#,2
/#SCALE
'ROUP n n n
'ROUP n n n
'3)SCALE
'ROUP n n n
'ROUP n n n
0/-3
'ROUP n n n
'ROUP n n n
033
'ROUP n n n
'ROUP n n n
0),
'ROUP n n n
'ROUP n n n
9"/#39ALE"ROWN /BSESSIVE#OMPULSIVE 3CALE 3#,23YMPTOM #HECKLIST 2EVISED /#OBSESSIVECOMPULSIVE '3)GLOBAL SEVERITY INDEX
0/-30ROFILEOF-OODS3CALE0330ERCEIVED3TRESS3CALE0),0URPOSEIN,IFETEST
-EANVALUESSTANDARDDEVIATIONS3$SANDCONFIDENCEINTERVALS#)SFORGROUPSANDFOREACHTESTATTHEMONTHANDMONTHTESTPERIODS4HE
MONTHMEANSMINUSTHEMONTHMEANSAREEXPRESSEDASTHEDIFFERENCESCORESCHANGESCORESFOREACHGROUPANDSCALE4HEINDEPENDENTGROUPS3TUDENTS
TTESTTWOTAILEDWASUSEDTOCALCULATETHESIGNIFICANTDIFFERENCESFORIMPROVEMENTFOREACHGROUP4HE0VALUESAREPROVIDEDFORTHE9"/#33#,2/#
AND3#,2'3)0/-3033AND0),'ROUPIMPROVEMENTSWERESIGNIFICANTLYGREATERTHANGROUPFORTHE9"/#33#,2/#AND3#,2'3)AND
0/-3'ROUPIMPROVEDMORETHANGROUPONTHE033AND0),THEDIFFERENCESHOWEVERWERENOTSIGNIFICANT
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
AND
"ASEDONTHE9"/#3RESULTSTHE
GROUPSWEREMERGEDATTHEMONTHPERIOD
!NALYSISOF0HASE
!FTER MERGING THE STUDY POPULATION
INCLUDEDPATIENTSWHOCOMPLETEDMONTHS
OFTHEORIGINALADULTS/NEOFTHE
ADULTWOMENFROMGROUPWHOWITHDREWPRIOR
TOMONTHSPATIENTCHOSETOREENTER!LSO
THREENEWCANDIDATESWHOCOULDNOTPARTICI
PATEEARLIERDUETOTIMECONFLICTSENTEREDTHE
TRIALINPHASETWOWOMENPATIENTAGED
YEARSANDPATIENTAGEDYEARSAND
ONEADOLESCENTBOYWITH4OURETTESYNDROME
PATIENTAGEDYEARS0ATIENTSAND
WERETAKINGMEDICATIONFOR/#$%IGHTEEN
PATIENTSSTARTEDPHASEBUTTHREEPATIENTS
ANDWITHDREWAFTERSEVERALWEEKS
4HEMONTHMEANS3$AND#)SFROM
MONTHTOMONTHFORALLSUBJECTSCOMPLET
INGTESTSFORATLEASTTWOINTERVALSAREPRESENTED
IN4ABLE4HEMULTIPLERANGETESTRESULTSFOR
SIGNIFICANCELEVEL4UKEYTESTFORCOMPAR
INGTHEMEANSCORESATTHEVARIOUSINTERVALSARE
INTHELEGEND!NANALYSISOFVARIANCE!./6!
DEMONSTRATEDIMPROVEMENTSFORTHESEPATIENTS
ONTHE9"/#3&;=0
3#,2/#&;=0
3#,2'3)&;=0
0/-34-$SCALE&;=0
033&;=0AND 0),
&;=0)NADDITIONASUB
GROUPANALYSISOFTHESEVENPATIENTSINITIALLY
INGROUPSHOWEDAIMPROVEMENTINTHE
9"/#3FORTHEFIRSTMONTHSUSINGTHE+9
PROTOCOL4HISPARALLELEDTHEIMPROVE
MENTFORTHESEVENPATIENTSORIGINALLYINGROUP
DURINGTHEIRFIRSTMONTHS
7EALSOCALCULATEDTHESTATISTICSSEPA
RATELYFORTHOSESUBJECTSWHOWEREORIGI
NALLYINGROUPOVERTHEIRMONTHSOF+9
ANDTHOSEORIGINALLYINGROUPINCLUDING
PATIENTWHOENTEREDTHESTUDYATMONTH
FORTHEIR MONTHSOF+94HE ONE
WAYREPEATEDMEASURES!./6!FORTHE9
"/#33#,2/#SCALE3#,2'3)
SCALE0/-3033AND0),TESTSRESPEC
TIVELYFORGROUPMONTHSTOWERE
&0&
0 & 0
&0&
0AND&04HE
RESPECTIVEGROUPVALUESFORMONTHSTO
IEMONTHSOF+9THERAPYWERE
&0&
0 & 0
&0&
0AND&0
"OTH POPULATIONS SHOWEDSIGNIFICANT
IMPROVEMENTSWITHUSEOFTHE+9PROTOCOL
FORALLSCALESUSINGAN!./6!7HENTHE
MONTHBASELINE.MEANWASCOMPARED
WITHTHEMONTHMEAN.THEIMPROVE
MENTSATMONTHSWEREONTHE9
"/#3ONTHE3#,2/#SCALE
ONTHE3#,2'3)SCALE
ON0/-3ON033ANDONTHE
0),TEST&ORTHESEPATIENTSTHE9"/#3
TOTALSINCLUDEDTHREESCORESOFONESCOREOF
TWOSCORESOFONESCOREOFANDONESCORE
EACHOFAND
3IXOFTHEPATIENTSWHOENTEREDTHE
PROTOCOLWHILETAKINGMEDICATIONCOMPLETED
THESTUDY4HREEOFTHESESIXWEREFREEOF
MEDICATIONFORAMINIMUMOFMONTHSPRIOR
TOSTUDYEND4HEOTHERSWEREABLETOREDUCE
THEIRMEDICATIONDOSAGE
&EATURE!RTICLE/RIGINAL2ESEARCH
4!",%!,,039#(/,/')#!,3#!,%-/.4().4%26!,-%!.6!,5%3!.$#/.&)$%.#%).4%26!,3
MONTH3$#) MONTH3$#) MONTH3$#) MONTH3$#) MONTH3$#) MONTH3$#)
9"/#3TOTALS n n n n n n
3#,2
/#SCALE n n n n n n
'3)SCALE n n n n n n
0/-34-$ n n n n n TO
033 n n n n n n
0), n n n n n n
9"/#39ALE"ROWN /BSESSIVE #OMPULSIVE 3CALE 3#,23YMPTOM #HECKLIST 2EVISED /#OBSESSIVECOMPULSIVE '3)GLOBAL SEVERITY INDEX
0/-30ROFILEOF-OOD3TATES0330ERCEIVED3TRESS3CALE0),0URPOSEIN,IFESCALE
4HEMEANANDSTANDARDDEVIATION3$ANDCONFIDENCEINTERVALS#)SAREPROVIDEDFOREACHSCALEFORALLMONTHINTERVALMEASURES.
ANDFORTHEANDMONTHMEASURESRESPECTIVELY2EFLECTSPARTICIPANTSWHOREMAINEDINTHESTUDYFORATLEASTTWOMONTHTESTINTERVALS
4HE9"/#3MULTIPLERANGETESTRESULTSFORSIGNIFICANCELEVEL4UKEYTESTSHOWTHATMONTHMONTHMONTHMONTHMONTHMONTH
4HE 3#,2/# SCALE SHOWS THAT MONTH MONTH MONTH MONTH MONTHMONTH AND THE 3#,2'3) SCALE SHOWS
THATMONTHMONTH4HE0/-34-$SCORESSHOWTHATMONTHMONTHMONTHMONTHMONTHMONTH4HE033SHOWSTHAT
MONTHMONTHMONTHMONTHMONTHMONTH4HE0),SHOWSTHATMONTHMONTHMONTHMONTHMONTH
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
$)3#533)/.
4HEPRESENTINVESTIGATIONANDOURUNCON
TROLLEDSTUDY
YIELDEDSIMILARRESULTSDEM
ONSTRATINGREPRODUCIBILITYANDSUGGESTING
THATTHE+9PROTOCOLHASTHERAPEUTICVALUE
WITHOUTAPPARENTSIDEEFFECTS3INCETHE
GROUPUSING22AND--SHOWEDNOSIGNIFI
CANTIMPROVEMENTITCANBEASSUMEDTHAT
THEIMPROVEMENTSINTHE+9GROUPARENOT
THECONSEQUENCEOFAPLACEBOEFFECTOROF
ATTENTIONBUTRATHERATHERAPYSPECIFICFACTOR
7HILETHE+9PROTOCOLINCLUDEDATECHNIQUE
CLAIMEDBYYOGISTOBESPECIFICFOR/#$
THISPROTOCOLWASCOMPLEXTHEREFOREITIS
NOTCLEARWHICHCOMPONENTSLEDTOEFFICACY
3TUDIESEVALUATINGSUBJECTSONTHEBASISOF
ELECTROENCEPHALOGRAPHY
MAGNETOENCEPHA
LOGRAPHY-%'
COGNITIVEPERFORMANCE
ANDMOOD
ALLDEMONSTRATETHATLEFTNOSTRIL
BREATHINGTECHNIQUESSELECTIVELYSTIMULATE
THERIGHTHEMISPHEREOFTHEBRAIN4HERESULTS
OFOTHERREVIEWS
IDENTIFYRIGHTHEMISPHERIC
ABNORMALITIESWITH/#$
SUGGESTINGTHATTHE
EFFICACYOFTHISYOGICTECHNIQUEMAYBEDUETO
ARELATEDEFFECT/URPRELIMINARYUNPUBLISHED
-%'RESULTSONTHEEFFECTSOFTHEPURPORTEDLY
/#$SPECIFICLEFTNOSTRILBREATHINGTECHNIQUE
INATRAINEDNORMALSUBJECTSUGGESTTHATWHILE
STIMULATIONOFTHERIGHTHEMISPHEREISDIFFUSE
ANDDRAMATICASTRONGEFFECTONTHEFRONTAL
ANDPREFRONTALRIGHTHEMISPHEREMAYHELPTO
COMPENSATEFORTHE/#$RELATEDDEFECT
/URRESULTSAREENCOURAGINGWHENCOMPARED
WITHTHOSEFROMARECENTMULTICENTERDOUBLE
BLINDPLACEBOCONTROLLEDFLUVOXAMINESTUDY
THATSHOWEDA9"/#3IMPROVEMENTFOR
ACTIVETHERAPYNMEANCHANGEAND
AIMPROVEMENTFORPLACEBONMEAN
CHANGE/URMEAN9"/#3CHANGEOF
OVERMONTHSWITHOURCON
TROLGROUPMAYBEAPLACEBOEFFECT(OWEVER
THE+9PROTOCOLCHANGEATMONTHS
NMEANCHANGEANDMONTHS
NMEANCHANGEISALSOWELLBEYOND
THETOPLACEBOEFFECTOBSERVEDINA
DOUBLEBLINDPLACEBOCONTROLLEDSTUDYOF
CLOMIPRAMINE
)NADDITIONINACOMPARISON
OFRESULTSFROMFOURMULTICENTERPLACEBOCON
TROLLEDTRIALSOFCLOMIPRAMINEFLUOXETINE
FLUVOXAMINEANDSERTRALINE'RIESTETAL
FOUND
RESPECTIVE9"/#3IMPROVEMENTSOF
ANDFORTHEBESTDOSECOMPARISONS
!MONGTHEPUBLISHEDSTUDIESON"4-ARKS
CONCLUDEDTHATTHISINTERVENTIONCONSISTENTLY
ACHIEVESARATINGOFMUCHIMPROVEDIN
TOOFPATIENTSFOLLOWINGBRIEFTREATMENT
4HESEIMPROVEMENTSAREMAINTAINEDAFTER
TOYEARSOFFOLLOWUP3UMMARIZINGSTUD
IESOF"4CONDUCTEDMOSTLYONANINPATIENT
BASISAROUNDTHEWORLDOVERTHELASTDECADES
"AER
CONCLUDEDTHATAPPROXIMATELYOF
/#$PATIENTShGETCONTROLOFTHEIRSYMPTOMSv
ANDTHATAREABLETOCOMPLETE"4/FTHE
REMAININGMOSTSUCCUMBTOEXTREMEFEAR
)NADDITION#OTTRAUX
FOUNDTHATONEQUAR
TEROFPATIENTSEITHERREFUSETREATMENTORDROP
OUTEARLYIN"4THERAPY/FTHOSEREMAININGIN
THERAPYDONOTIMPROVEANDOFTHE
IMPROVEDPATIENTSREQUIREhBOOSTERTREATMENTv
FORSOMESUBSEQUENTLOSSOFGAINS
4HEMAJORITYOFTHEABOVE"4STUDIESHOW
EVERINCLUDEDPATIENTSWHOSEPRIMARY/#$RIT
UALSWERECLEANINGANDCHECKING
WHICHARETHEMOSTEASILYTREATEDFORMSOF/#$
USING"4
)NADDITIONTHEEARLIER"4STUDIESDID
NOTUSETHE9"/#3THECURRENTGOLDSTANDARD
FORMEASURING/#$SEVERITY&URTHERMORETHE
ACUTEEFFECTSOFEXPOSUREANDRESPONSEPREVEN
TIONOFTENLEADTOANIMMEDIATEANDINCREASED
LEVELOFFEARANDANXIETYAFFECTINGTHEPATIENTS
WILLINGNESSTOCOMPLYWITHTREATMENT
/URPATIENTSHADDIVERSEANDMULTIPLE
/#SYMPTOMS&ORTHEPATIENTSWHOCOM
PLETEDMONTHSOFTHERAPYTHEMEAN9
"/#3OBSESSIONSCOREDECREASEDFROM
3$#)nATBASELINE
TO3$#)nAT
MONTHSCOMPULSIONSCORESDECREASEDFROM
3$#)nTO
3$#)n!LLPATIENTS
WERETREATEDIDENTICALLYTHUSELIMINATINGTHE
NEEDFORANINDIVIDUALIZEDTREATMENTPLAN
'ROUPTHERAPYREDUCESTHEFINANCIALCOSTS
TOTHEPATIENTANDMINIMIZESTHERAPISTTIME
HOWEVERTHETIMECOURSEFORTREATMENTISLONG
ANDREQUIRESNEARWEEKLYATTENDANCEANDCON
SIDERABLEHOMEWORKCOMPARABLETO"4/UR
EXPERIENCESHOWSTHATAPPROXIMATELYYEARIS
REQUIREDTOACHIEVEMAXIMALOUTCOMES4HIS
RESEARCHISPRELIMINARYANDFURTHERINVESTIGA
TIONMUSTBECONDUCTEDWITHLARGERPOPULATIONS
TESTINGVARIOUSCOMBINATIONSOF+9TECHNIQUES
TOPERHAPSREFINETHEPROTOCOLANDATTEMPT
TREATMENTWITHYOUNGERPATIENTS
#.3
&EATURE!RTICLE/RIGINAL2ESEARCH
h4HEPRESENT
INVESTIGATIONAND
OURUNCONTROLLED
STUDYYIELDEDSIMILAR
RESULTSDEMONSTRATING
REPRODUCIBILITYAND
SUGGESTINGTHATTHE+9
PROTOCOLHASTHERAPEUTIC
VALUEWITHOUTAPPARENT
SIDEEFFECTSv
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.
6OLUMEn.UMBERs$ECEMBER
# . 3 3 0 % # 4 2 5 - 3
2%&%2%.#%3
2APOPORT *, 4HE WAKING NIGHTMARE AN OVERVIEW OF
OBSESSIVE COMPULSIVE DISORDER * #LIN 0SYCHIATRY
2ASMUSSEN 3! %ISEN *, %PIDEMIOLOGY OF OBSESSIVE
COMPULSIVEDISORDER*#LIN0SYCHIATRY
*ENIKE -! 0SYCHOTHERAPY OF THE PATIENT WITH OBSESSIVE
COMPULSIVE PERSONALITY DISORDER )N *ENIKE -! "AER ,
-INICHIELLO7%EDS/BSESSIVE#OMPULSIVE$ISORDERS4HEORY
AND-ANAGEMENT3T,OUIS-O-OSBY9EAR"OOK
'OODMAN7+-C$OUGLE#*0RICE,(0HARMACOTHERAPY
OF OBSESSIVE COMPULSIVE DISORDER * #LIN 0SYCHIATRY
*ENIKE-!0HARMACOLOGICTREATMENTOFOBSESSIVECOMPUL
SIVEDISORDERS0SYCHIATR#LIN.ORTH!M
'OODMAN 7+ 0RICE ,( 2ASMUSSEN 3! ET AL 4HE
9ALE"ROWN /BSESSIVE #OMPULSIVE 3CALE !RCH 'EN
0SYCHIATRY
'OODMAN7+-C$OUGLE#*"ARR,#!RONSON3#0RICE
,("IOLOGICALAPPROACHESTOTREATMENTRESISTANTOBSESSIVE
COMPULSIVEDISORDER*#LIN0SYCHIATRY
0ATO -4 :OHAR+ADOUCH 2 :OHAR * -URPHY $,
2ETURN OF SYMPTOMS AFTER DISCONTINUATION OF CLOMIP
RAMINEIN PATIENTSWITHOBSESSIVECOMPULSIVE DISORDER
!M*0SYCHIATRY
,EONARD (, ET AL ! DOUBLEBLIND SUBSTITUTION DURING
LONGTERMCLOMIPRAMINETREATMENTINCHILDRENANDADO
LESCENTS!RCH'EN0SYCHIATRY
&ONTAINE 2 #HOUINARD ' &LUOXETINE IN THE LONGTERM
TREATMENT OF OBSESSIVE COMPULSIVE DISORDER 0SYCHIATR
!NN
+OBAK +! 'RIEST *( *EFFERSON *7 +ATZELNICK $*
(ENK(*"EHAVIORALVERSUSPHARMACOLOGICALTREATMENTS
OF OBSESSIVE COMPULSIVE DISORDER A METAANALYSIS
0SYCHOPHARMACOLOGY
/3ULLIVAN ' .OSHIRVANI ( -ARKS ) -ONTEIRO 7
,ELLIOTT03IXYEARFOLLOWUPAFTEREXPOSUREANDCLOMIP
RAMINETHERAPYFOROBSESSIVECOMPULSIVEDISORDER*#LIN
0SYCHIATRY
-ARKS )- 2EVIEW OF BEHAVIORAL PSYCHOTHERAPY !M *
0SYCHIATRY
3HANNAHOFF+HALSA$3"ECKETT,2#LINICALCASEREPORT
EFFICACYOFYOGICTECHNIQUESINTHETREATMENTOFOBSESSIVE
COMPULSIVEDISORDER)NT*.EUROSCI
$EROGATIS ,2 3YMPTOM #HECKLIST2EVISED
-INNEAPOLIS-INN.ATIONAL#OMPUTER3YSTEMS
3HANNAHOFF+HALSA$39OGICMEDITATIONTECHNIQUESARE
EFFECTIVEINTHETREATMENTOFOBSESSIVECOMPULSIVEDISOR
DERS)N(OLLANDER%3TEIN$EDS/BSESSIVE#OMPULSIVE
$ISORDERS%TIOLOGY$IAGNOSISAND4REATMENT.EW9ORK
.9-ARCEL$EKKER
$IAGNOSTICAND 3TATISTICAL-ANUALOF -ENTAL $ISORDERS
RD ED REV 7ASHINGTON $# !MERICAN 0SYCHIATRIC
!SSOCIATION
3HANNAHOFF+HALSA $3 3TRESS TECHNOLOGY MEDICINE A
NEW PARADIGM FOR STRESS AND CONSIDERATIONS FOR SELF
REGULATION)N"ROWN-2+OOB'2IVIER#EDS3TRESS
.EUROBIOLOGY AND .EUROENDOCRINOLOGY .EW 9ORK .9
-ARCEL$EKKER
"ENSON ( 4HE 2ELAXATION 2ESPONSE .EW 9ORK .9
-ORROW
+ABAT:INN*!NOUTPATIENTPROGRAMINBEHAVIORALMED
ICINEFORCHRONICPAINPATIENTSBASEDONTHEPRACTICEOF
MINDFULNESS MEDITATION THEORETICAL CONSIDERATIONS AND
PRELIMINARYRESULTS'EN(OSP0SYCHIATRY
+ABAT:INN*&ULL#ATASTROPHE,IVING5SINGTHE7ISDOM
OF9OUR"ODYAND-INDTO&ACE3TRESS0AINAND)LLNESS
.EW9ORK.9$ELACORTE0RESS
+OBAK +! 'REIST *( *EFFERSON *7 +ATZELNICK $*
#OMPUTERADMINISTEREDCLINICALRATINGSCALESAREVIEW
0SYCHOPHARMACOLOGY
-C.AIR$- ,ORR- $ROPPLEMAN,&0ROFILE OF-OODS
3CALE 3AN $IEGO #ALIF %DUCATIONAL AND )NDUSTRIAL
4ESTING3ERVICE
#OHEN3+AMARCK4-ERMELSTEIN2!GLOBALMEASURE
OFPERCEIVEDSTRESS0ERCEIVED3TRESS3CALE4HE*OURNAL
OF(EALTHAND(UMAN"EHAVIOR
#RUMBAUGH *# -AHOLICK ,4 0URPOSE IN ,IFE 4EST
4EST &ORM ! -URFREESBORO 4ENN 0SYCHOMETRIC
!FFILIATES
7OODY323TEKETEE'#HAMBLESS$,2ELIABILITYAND
VALIDITYOFTHE9ALE"ROWN/BSESSIVE#OMPULSIVE3CALE
"EHAV2ES4HER
7OODY323TEKETEE'#HAMBLESS$,4HEUSEFULNESSOF
THEOBSESSIVECOMPULSIVESCALEOFTHE3YMPTOM#HECKLIST
2EVISED"EHAV2ES4HER
7ERNTZ $! "ICKFORD 2' 3HANNAHOFF+HALSA $3
3ELECTIVE HEMISPHERIC STIMULATION BY UNILATERAL FORCED
NOSTRILBREATHING(UMAN.EUROBIOLOGY
3HANNAHOFF+HALSA$3"OYLE-2"UEBEL-4HEEFFECTS
OFUNILATERALFORCEDNOSTRILBREATHINGONCOGNITION)NT*
.EUROSCI
*ELLA3!3HANNAHOFF+HALSA$3 4HE EFFECTSOF UNILAT
ERAL FORCED NOSTRILBREATHINGON COGNITIVE PERFORMANCE
)NT*.EUROSCI
3CHIFF""2UMP3!!SYMMETRICALHEMISPHERICACTIVA
TIONANDEMOTIONTHEEFFECTSOFUNILATERALFORCEDNOSTRIL
BREATHING"RAINAND#OGNITION
"REITER (# 2AUCH 3, +WONG ++ ET AL &UNCTIONAL
MAGNETIC RESONANCE IMAGING OF SYMPTOM PROVOCATION
INOBSESSIVECOMPULSIVEDISORDER!RCH'EN 0SYCHIATRY
'OODMAN 7+ +OZAK -* ,IEBOWITZ - 7HITE +,
4REATMENTOFOBSESSIVECOMPULSIVEDISORDERWITHFLUVOX
AMINE A MULTICENTER DOUBLEBLIND PLACEBOCONTROLLED
TRIAL)NT#LIN0SYCHOPHARMACOL
'RIEST *( *EFFERSON *7 2OSENFELD 2 'UTZMANN ,$
-ARCH *3 "ARKLAGE .% #LOMIPRAMINE AND OBSESSIVE
COMPULSIVE DISORDER A PLACEBOCONTROLLED DOUBLEBLIND
STUDYOFPATIENTS*#LIN0SYCHIATRY
'RIEST *( *EFFERSON *7 +OBAK +! +ATZELNICK $*
3ERLIN 2# %FFICACY AND TOLERABILITY OF SEROTONIN TRANS
PORT INHIBITORS IN OBSESSIVECOMPULSIVE DISORDER !RCH
'EN0SYCHIATRY
-ARKS )- 2EVIEW OF BEHAVIORAL PSYCHOTHERAPY !M *
0SYCHIATRY
"AER,'ETTING#ONTROL/VERCOMING9OUR/BSESSIONSAND
#OMPULSIONS"OSTON-ASS,ITTLE"ROWN#O
#OTTRAUX*"EHAVIORALPSYCHOTHERAPYFOROBSESSIVECOM
PULSIVE DISORDER )NTERNATIONAL 2EVIEW OF 0SYCHIATRY
"AER,-INICHIELLO7%"EHAVIORTHERAPYFOROBSESSIVE
COMPULSIVEDISORDER)N*ENIKE-!"AER,-INICHIELLO
7% EDS /BSESSIVE#OMPULSIVE $ISORDERS 4HEORY AND
-ANAGEMENT3T,OUIS-O-OSBY9EAR"OOK
&EATURE!RTICLE/RIGINAL2ESEARCH
hFURTHERINVESTIGATION
MUSTBECONDUCTED
WITHLARGERPOPULATIONS
TESTINGVARIOUSCOMBIN
ATIONSOF+9TECHNIQUES
TOPERHAPSREFINETHE
PROTOCOLANDATTEMPT
TREATMENTWITH
YOUNGERPATIENTSv
© 2008, MBL Communications, Inc.
All Rights Reserved.
For Electronic Distribution Only.